Language:

Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study

Giannini, Marta ; Portaccio, Emilio ; Ghezzi, Angelo ; Hakiki, Bahia ; Pastò, Luisa ; Razzolini, Lorenzo ; Piscolla, Elisa ; De Giglio, Laura ; Pozzilli, Carlo ; Paolicelli, Damiano ; Trojano, Maria ; Marrosu, Maria Giovanna ; Patti, Francesco ; La Mantia, Loredana ; Mancardi, Gianluigi ; Solaro, Claudio ; Totaro, Rocco ; Tola, Maria Rosaria ; De Luca, Giovanna ; Lugaresi, Alessandra ; Moiola, Lucia ; Martinelli, Vittorio ; Comi, Giancarlo ; Amato, Maria Pia

BMC neurology, 2012-10, Vol.12 (1), p.124-124, Article 124 [Peer Reviewed Journal]

England: BioMed Central Ltd

Full text available

Citations Cited by

Actions
1. Add to e-Shelf
2. Remove from e-Shelf
3. E-mail
4. Print
5. Permalink
6. Citation
7. EasyBib
8. EndNote
9. RefWorks
10. Delicious
11. Export RIS
12. Export BibTeX

Title:
Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study
Author: Giannini, Marta ; Portaccio, Emilio ; Ghezzi, Angelo ; Hakiki, Bahia ; Pastò, Luisa ; Razzolini, Lorenzo ; Piscolla, Elisa ; De Giglio, Laura ; Pozzilli, Carlo ; Paolicelli, Damiano ; Trojano, Maria ; Marrosu, Maria Giovanna ; Patti, Francesco ; La Mantia, Loredana ; Mancardi, Gianluigi ; Solaro, Claudio ; Totaro, Rocco ; Tola, Maria Rosaria ; De Luca, Giovanna ; Lugaresi, Alessandra ; Moiola, Lucia ; Martinelli, Vittorio ; Comi, Giancarlo ; Amato, Maria Pia
Subjects: Abortion ; Acetates ; Adult ; Analysis ; Biological response modifiers ; Care and treatment ; Comorbidity ; Confidence intervals ; Drug therapy ; Drug-Related Side Effects and Adverse Reactions - epidemiology ; Family planning ; Female ; Glatiramer Acetate ; Health aspects ; Humans ; In utero exposure ; Incidence ; Interferon beta ; Italy - epidemiology ; Male ; Multiple sclerosis ; Multiple Sclerosis - drug therapy ; Multiple Sclerosis - epidemiology ; Neurology ; Neurosciences ; Patient outcomes ; Peptides - therapeutic use ; Pharmaceutical industry ; Postpartum period ; Pregnancy ; Pregnancy outcome ; Pregnancy Outcome - epidemiology ; Pregnant women ; Prenatal Exposure Delayed Effects - epidemiology ; Risk Assessment ; Studies ; Treatment Outcome
Is Part Of: BMC neurology, 2012-10, Vol.12 (1), p.124-124, Article 124
Notes: ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
Description: Only few studies have assessed safety of in utero exposure to glatiramer acetate (GA). Following a previous study assessing the safety of interferon beta (IFNB) pregnancy exposure in multiple sclerosis (MS), we aimed to assess pregnancy and fetal outcomes after in utero exposure to GA, using the same dataset, with a specific focus on the risk of spontaneous abortion. We recruited MS patients, prospectively followed-up in 21 Italian MS Centres, for whom a pregnancy was recorded in the period 2002-2008. Patients were divided into 2 groups: drug-exposed pregnancies (EP: suspension of the drug less than 4 weeks from conception); non-exposed pregnancies (NEP: suspension of the drug at least 4 weeks from conception or never treated pregnancies). All the patients were administered a structured interview which gathered detailed information on pregnancy course and outcomes, as well as on possible confounders. Multivariate logistic and linear models were used for treatment comparisons. Data on 423 pregnancies were collected, 17 were classified as EP to GA, 88 as EP to IFNB, 318 as NEP. Pregnancies resulted in 16 live births in the GA EP, 75 live births in the IFNB EP, 295 live births in the NEP. GA exposure was not significantly associated with an increased risk of spontaneous abortion (OR = 0.44;95% CI 0.044-4.51;p = 0.49). Mean birth weight and length were not significantly different in pregnancies exposed to GA than in non exposed pregnancies (p = 0.751). The frequency of preterm delivery, observed in 4 subjects exposed to GA (25% of full term deliveries), was not significantly higher in pregnancies exposed to GA than in those non exposed (p > 0.735). These findings were confirmed in the multivariate analysis. There were neither major complications nor malformations after GA exposure. Data in our cohort show that mother's GA exposure is not associated with a higher frequency of spontaneous abortion, neither other negative pregnancy and fetal outcomes. Our findings point to the safety of in utero GA exposure and can support neurologists in the therapeutic counselling of MS women planning a pregnancy.
Publisher: England: BioMed Central Ltd
Language: English

Links

View this record in MEDLINE/PubMed

Back to results list

Previous Result 2 Next Go to Next page

Implemented by: Social Network Logos:

Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study

England: BioMed Central Ltd

Searching Remote Databases, Please Wait